The Company’s intangible assets at June 30, 2021 include patents with estimated remaining economic useful lives ranging from 0.25 to 12.25 years. For all periods presented, all of the Company’s patents were subject to amortization. The gross carrying amou (Details) - USD ($) |
Jun. 30, 2021 |
Dec. 31, 2020 |
|---|---|---|
| Acquired Finite-Lived Intangible Assets [Line Items] | ||
| Patents, net | $ 1,498,000 | $ 1,578,000 |
| Patents [Member] | ||
| Acquired Finite-Lived Intangible Assets [Line Items] | ||
| Gross carrying amount - patents | 7,915,000 | 7,848,000 |
| Accumulated amortization - patents | (6,417,000) | (6,270,000) |
| Patents, net | $ 1,498,000 | $ 1,578,000 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Gross carrying amount before accumulated amortization as of the balance sheet date of the costs pertaining to the exclusive legal rights granted to the owner of the patent to exploit an invention or a process for a period of time specified by law. Such costs may have been expended to directly apply and receive patent rights, or to acquire such rights. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|